blonanserin has been researched along with phencyclidine in 4 studies
Studies (blonanserin) | Trials (blonanserin) | Recent Studies (post-2010) (blonanserin) | Studies (phencyclidine) | Trials (phencyclidine) | Recent Studies (post-2010) (phencyclidine) |
---|---|---|---|---|---|
121 | 21 | 93 | 28,294 | 387 | 7,796 |
Protein | Taxonomy | blonanserin (IC50) | phencyclidine (IC50) |
---|---|---|---|
Glutamate receptor ionotropic, NMDA 1 | Rattus norvegicus (Norway rat) | 0.1299 | |
Lysosomal Pro-X carboxypeptidase | Homo sapiens (human) | 0.091 | |
Glutamate receptor ionotropic, NMDA 2A | Rattus norvegicus (Norway rat) | 0.1299 | |
Glutamate receptor ionotropic, NMDA 2B | Rattus norvegicus (Norway rat) | 0.1299 | |
Glutamate receptor ionotropic, NMDA 2C | Rattus norvegicus (Norway rat) | 0.1299 | |
Glutamate receptor ionotropic, NMDA 1 | Homo sapiens (human) | 0.5563 | |
Glutamate receptor ionotropic, NMDA 2A | Homo sapiens (human) | 0.205 | |
Glutamate receptor ionotropic, NMDA 2B | Homo sapiens (human) | 1.2589 | |
Glutamate receptor ionotropic, NMDA 2D | Rattus norvegicus (Norway rat) | 0.1299 | |
Glutamate receptor ionotropic, NMDA 3B | Rattus norvegicus (Norway rat) | 0.1299 | |
Sigma non-opioid intracellular receptor 1 | Rattus norvegicus (Norway rat) | 0.53 | |
Glutamate receptor ionotropic, NMDA 3A | Rattus norvegicus (Norway rat) | 0.1299 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (25.00) | 29.6817 |
2010's | 3 (75.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Furukawa, H; Furukawa, K; Kan, QM; Nabeshima, T; Nagai, T; Noda, Y; Une, T | 1 |
Horiguchi, M; Meltzer, HY | 1 |
Hida, H; Iwamoto, K; Matsumoto, Y; Mori, K; Mouri, A; Nabeshima, T; Noda, Y; Ozaki, N; Seki, T; Taniguchi, M; Yamada, K | 1 |
Huang, M; Kwon, S; Meltzer, HY; Miyauchi, M; Oyamada, Y; Rajagopal, L | 1 |
4 other study(ies) available for blonanserin and phencyclidine
Article | Year |
---|---|
Effect of AD-5423 on animal models of schizophrenia: phencyclidine-induced behavioral changes in mice.
Topics: Animals; Disease Models, Animal; Immobilization; Male; Mice; Motor Activity; Phencyclidine; Piperazines; Piperidines; Schizophrenia | 2003 |
Blonanserin reverses the phencyclidine (PCP)-induced impairment in novel object recognition (NOR) in rats: role of indirect 5-HT(1A) partial agonism.
Topics: Animals; Female; Isoindoles; Phencyclidine; Piperazines; Piperidines; Pyridines; Pyrimidines; Rats; Rats, Long-Evans; Receptor, Serotonin, 5-HT1A; Recognition, Psychology; Serotonin 5-HT1 Receptor Agonists; Serotonin 5-HT2 Receptor Antagonists | 2013 |
Blonanserin ameliorates phencyclidine-induced visual-recognition memory deficits: the complex mechanism of blonanserin action involving D₃-5-HT₂A and D₁-NMDA receptors in the mPFC.
Topics: Amphetamines; Animals; Benzazepines; Benzodiazepines; Dopamine; Dopamine Agonists; Isoquinolines; Male; Mice; Olanzapine; Phencyclidine; Phosphorylation; Piperazines; Piperidines; Prefrontal Cortex; Protein Kinase Inhibitors; Receptors, Dopamine D1; Receptors, Dopamine D3; Receptors, N-Methyl-D-Aspartate; Recognition, Psychology; Serotonin Receptor Agonists; Sulfonamides; Tetrahydronaphthalenes | 2015 |
Dopamine D3 receptor antagonism contributes to blonanserin-induced cortical dopamine and acetylcholine efflux and cognitive improvement.
Topics: Acetylcholine; Animals; Benzopyrans; Brain Chemistry; Cerebral Cortex; Dopamine; Dopamine Antagonists; Excitatory Amino Acid Antagonists; Fluorenes; Haloperidol; Male; Mice; Mice, Inbred C57BL; Nootropic Agents; Oxazines; Phencyclidine; Piperazines; Piperidines; Rats, Long-Evans; Receptors, Dopamine D3 | 2015 |